Corus® CADCorus CAD is the only blood test that can quickly
and safely identify symptomatic patients unlikely to
have obstructive coronary artery disease (CAD).

 

Learn More >

Latest News COMPASS trial results presented at AHA Scientific Sessions 2011.  Corus CAD outperformed MPI in diagnostic accuracy and negative predictive value in the assessment of obstructive CAD.

Learn More >

PREDICT one-year data now published. Results provide evidence for the clinical utility of Corus CAD for safely excluding obstructive CAD as the cause of patient’s symptoms.

Learn More >

Women and Heart Disease
Learn more about women and heart disease, and assessment of obstructive coronary artery disease
in women. 

For Clinicians >

For Patients >